This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Erkmen CP , Dako F , Moore R , Dass C , Weiner MG , Kaiser LR , Ma GX
Adherence to annual lung cancer screening with low-dose CT scan in a diverse population
Cancer Causes Control. 2021 Mar;32(3) :291-298
PMID: 33394208 PMCID: PMC7878339 URL: https://www.ncbi.nlm.nih.gov/pubmed/33394208
AbstractPURPOSE: Our aim was to develop a novel approach for lung cancer screening among a diverse population that integrates the Centers for Medicare and Medicaid Services (CMS) recommended components including shared decision making (SDM), low-dose CT (LDCT), reporting of results in a standardized format, smoking cessation, and arrangement of follow-up care. METHODS: Between October of 2015 and March of 2018, we enrolled patients, gathered data on demographics, delivery of SDM, reporting of LDCT results using Lung-RADS, discussion of results, and smoking cessation counseling. We measured adherence to follow-up care, cancer diagnosis, cancer treatment, and smoking cessation at 2 years after initial LDCT. RESULTS: We enrolled 505 patients who were 57% African American, 30% Caucasian, 13% Hispanic, < 1% Asian, and 61% were active smokers. All participants participated in SDM, 88.1% used a decision aid, and 96.1% proceeded with LDCT. Of 496 completing LDCT, all received a discussion about results and follow-up recommendations. Overall, 12.9% had Lung-RADS 3 or 4, and 3.2% were diagnosed with lung cancer resulting in a false-positive rate of 10.7%. All 48 patients with positive screens but no cancer diagnosis adhered to follow-up care at 1 year, but only 35.4% adhered to recommended follow-up care at 2 years. The annual follow-up for patients with negative lung cancer screening results (Lung-RADS 1 and 2) was only 23.7% after one year and 2.8% after 2 years. All active smokers received smoking cessation counseling, but only 11% quit smoking. CONCLUSION: The findings show that an integrated lung cancer screening program can be safely implemented in a diverse population, but adherence to annual screening is poor.
Notes1573-7225 Erkmen, Cherie P Dako, Farouk Moore, Ryan Dass, Chandra Weiner, Mark G Kaiser, Larry R Ma, Grace X U54 CA221705/CA/NCI NIH HHS/United States U54 CA221704(5)/CA/NCI NIH HHS/United States Journal Article Netherlands Cancer Causes Control. 2021 Jan 4. doi: 10.1007/s10552-020-01383-0.